2Boyle M,Ting A,Cury DB,et al.Adherence to Rectal Mesalamine in Patients with Ulcerative Colitis [J].Inflam- matory bowel diseases, 2015,21 (12) : 2873-2878. 被引量：1
3Andreas CJ,Chen YC,MarKopoulos C,et al.In vitro biorelevant models for evaluating modified release mesalamine products to forecast the effect of formulation and meal intake on drug release [J].European journal of pharmaceuties and biopharmaceutics, 2015,97 (12) : 39 - 50. 被引量：1
4Kadiyala I,Jacobs D.The study of marKeted and experi- mental formulation approaches enabling site-specific de- livery of mesalamine in patients with inflammatory bowel disease [J ].Recent patents on drug delivery & formulation, 2014,8(1 ) :3-11. 被引量：1
